These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7527293)
21. Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. Grant S; Fitton A Drugs; 1994 Aug; 48(2):253-73. PubMed ID: 7527327 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of a new antipsychotic compound (risperidone): results of a pilot study. Möller HJ; Pelzer E; Kissling W; Riehl T; Wernicke T Pharmacopsychiatry; 1991 Nov; 24(6):185-9. PubMed ID: 1725925 [TBL] [Abstract][Full Text] [Related]
25. Schizophrenia and severe tardive dyskinesia responsive to risperidone. Kopala LC; Honer WG J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794 [No Abstract] [Full Text] [Related]
26. Clozapine in the management of schizophrenia. Risperidone is less toxic but equally effective. Menkes DB BMJ; 1993 Jul; 307(6897):200. PubMed ID: 7688254 [No Abstract] [Full Text] [Related]
27. Risperidone monotherapy in preschool children with pervasive developmental disorders. Masi G; Cosenza A; Mucci M; De Vito G J Child Neurol; 2001 Jun; 16(6):395-400. PubMed ID: 11417603 [TBL] [Abstract][Full Text] [Related]
28. Risperidone and remoxipride for schizophrenia. Drug Ther Bull; 1993 Dec; 31(26):101-2. PubMed ID: 7508364 [No Abstract] [Full Text] [Related]
29. Risperidone for chronic schizophrenia. Med Lett Drugs Ther; 1994 Apr; 36(920):33-4. PubMed ID: 7511777 [No Abstract] [Full Text] [Related]
30. Unexpected dystonia while changing from clozapine to risperidone. Radford JM; Brown TM; Borison RL J Clin Psychopharmacol; 1995 Jun; 15(3):225-6. PubMed ID: 7543499 [No Abstract] [Full Text] [Related]
31. Risperidone (R64 766) in psychotic patients. A first clinical therapeutic exploration. Roose K; Gelders Y; Heylen S Acta Psychiatr Belg; 1988; 88(3):233-41. PubMed ID: 2466393 [TBL] [Abstract][Full Text] [Related]
33. New drug offers hope for people with schizophrenia. J Psychosoc Nurs Ment Health Serv; 1994 May; 32(5):46. PubMed ID: 7519676 [No Abstract] [Full Text] [Related]
34. Use of risperidone in developmentally disabled children. Kastner TA Pediatrics; 2005 May; 115(5):1447-8; author reply 1448. PubMed ID: 15867075 [No Abstract] [Full Text] [Related]
35. Risperidone in children and adolescents with pervasive developmental disorder: pilot trial and follow-up. Perry R; Pataki C; Munoz-Silva DM; Armenteros J; Silva RR J Child Adolesc Psychopharmacol; 1997; 7(3):167-79. PubMed ID: 9466234 [TBL] [Abstract][Full Text] [Related]
36. Recent developments in antipsychotic therapy. Introduction. Love RC Am J Health Syst Pharm; 1995 Feb; 52(3 Suppl 1):S3-4. PubMed ID: 7538436 [No Abstract] [Full Text] [Related]
37. Clinical review of risperidone. Chouinard G; Arnott W Can J Psychiatry; 1993 Sep; 38 Suppl 3():S89-95. PubMed ID: 7504574 [TBL] [Abstract][Full Text] [Related]
38. Methylphenidate an effective treatment for ADHD? McDougle CJ J Autism Dev Disord; 2004 Oct; 34(5):593-4. PubMed ID: 15628613 [No Abstract] [Full Text] [Related]
39. Role of risperidone in children with autism spectrum disorder. Chavez B; Chavez-Brown M; Rey JA Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811 [TBL] [Abstract][Full Text] [Related]
40. Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study. Troost PW; Althaus M; Lahuis BE; Buitelaar JK; Minderaa RB; Hoekstra PJ J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):561-73. PubMed ID: 17069545 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]